New immune cell therapy aims to stop Leukemia's return in kids
NCT ID NCT07256210
Summary
This study is testing a new treatment for children and young adults with acute leukemia that has not responded well to standard chemotherapy. The treatment combines a stem cell transplant with infusions of specially boosted immune cells (NK cells) from a donor. The main goals are to see if this combined approach is safe, find the best dose, and see if it can help prevent the cancer from coming back after the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology
RECRUITINGMoscow, 117997, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.